Cancer News

Radiation therapy benefited some elderly breast cancer patients

A retrospective analysis revealed that elderly women with early stage triple negative breast cancer benefited from adjuvant radiation therapy after lumpectomy.

Conditional European approval for a rare blood cancer drug

The European health regulators conditionally approved Blincyto, a treatment for acute lymphoblastic leukemia (ALL), a rare blood cancer.

Skin cancer combination therapy one step closer to EU approval

Roche’s combination therapy for skin cancer received a positive opinion from the European Commission, bringing closer the approval of the drug for European patients.

Nivolumab brings hope to patients with advanced kidney cancer

The targeted drug nivolumab extended survival in patients with advanced kidney cancer whose disease has progressed on prior treatment, according to a new study.

Immunotherapy drug Opdivo improved survival in kidney cancer

The immunotherapy drug Opdivo extended survival rates in kidney cancer patients by more than two years, a new study reports.

The economic impact on families of children with cancer

The results of new study show that almost one-third of families of children with cancer face difficulties in meeting food, housing and energy needs during treatment.

FDA approves a toxic drug combination for colorectal cancer

The combination of trifluridine and tipiracil, once rejected because of its high toxicity levels, has being approved by the DFA for the treatment of colorectal cancer.

Exercise after a cancer diagnosis to extend survival

A new analysis of 70 existing studies revealed that in patients diagnosed with cancer, physical activity extended survival rates.

Emotions: a risk factor for postoperative pain in breast cancer

The emotional state of a breast cancer patient who undergoes surgical intervention is found to be a risk factor for acute postoperative pain, a new study reveals.

More personalized treatment needed for metastatic cancer patients

A new study reveals that for metastatic cancer patients, an individualized approach would be beneficial to select the most appropriate and effective therapy.

Experimental vaccine appears affective in cervical cancer patients

Advaxis’ experimental cancer vaccine improved survival rates in patients of cervical cancer compared with standard therapy, the company announced.

Results of cetuximab in advanced non-small cell lung cancer

A randomized trials showed that the added to chemotherapy inhibitor cetuximab failed to improve survival in patients with advanced non-small cell lung cancer.

Traditional chemotherapy with immunotherapy against lung cancer

Combining traditional chemotherapy with immunotherapy is safe for patients with advanced small cell lung cancer and non-small cell lung cancer, a new study reveals.

Do prostate cancer patients need treatment at all?

A new long-term study showed that treatment was unnecessary for the majority of older men diagnosed with low-risk prostate cancer and under an active surveillance scheme.

More therapeutic options against nausea and vomiting from chemotherapy

Tesaro’s Varubi got approved by the FDA for the prevention of delayed phase chemotherapy-induced nausea and vomiting.

Immunotherapy may not be a treatment option for some melanoma patients

Immunotherapy drug ipilimumab benefited only melanoma patients with a specific type of tumor-produced antigens, a new study reveals.

Combining immunotherapies for previously untreated lung cancer

Two immunotherapies, Opdivo and Yervoy can be safely and effectively combined to treat patients with previously untreated lung cancer, an early-stage study shows.

New treatment guidelines for advanced non-small cell lung cancer

The American Society of Clinical Oncology created a guideline to help doctors choose the best therapies for patients with advanced non-small cell lung cancer.

Active surveillance shows real promise in prostate cancer

Prostate cancer patients with relatively unaggressive tumors survived without surgery or radiation, due to an active surveillance program, a new study proves.

Acupuncture helps breast cancer patients control hot flashes

Acupuncture may offer relief for breast cancer patients against hot flashes, particular common when taking estrogen-taking therapies, according to a new study.

Beta-blockers related to better outcomes in ovarian cancer patients

Beta-blockers proved to be beneficial for ovarian cancer patients as they doubled survival, showed a clinical study of 1,425 patients.

Immunotherapy shows promise against drug-resistant multiple myeloma

Daratumumab, a breakthrough antibody therapy, showed very promising results in drug-resistant patients with multiple myeloma whose disease had relapsed.

Childhood cancer survivors face risk of recurrent stroke

Childhood cancer survivors are at a greater risk of suffering a stroke. These findings will lead to secondary stroke prevention strategies in high-risk patients.

Can alternative medicine compromise the efficacy of cancer drugs?

Senior oncology patients often use alternative medications together with their cancer treatment without knowing the potential drug-drug interactions.

An intervention helps women with breast cancer lose weight

Breast cancer patients often face difficulties in losing weight after treatment. Researchers now report that these women can lose weight with a personalized intervention.

Fertility concerns keep breast cancer patients away from treatment

Young women with breast cancer may refuse to be treated with the effective treatment, tamoxifen, due to the drug’s side effects on fertility.

One step closer to a new drug for multiple myeloma in Europe

European regulators have accepted the marketing authorization application for ixazomib, an investigational oral drug meant to treat relapsed/refractory myeloma patients.

Myeloma: the hope lies in the mutated genes

Researchers have discovered a method to identify which myeloma patients are at a greater risk of relapse and premature death.

Lynparza boosts gastric cancer overall survival

The combination of olaparib (Lynparza) and paclitaxel improved overall survival in high-risk gastric cancer patients, a new study revealed.

Brain volume loss caused by glioblastoma treatment

A new study reveals the specific structural and continuous brain changes resulting from standard radiation and chemotherapy in patients with glioblastoma.

Login to your account

Did you forget your password?